Found: 208
Select item for more details and to access through your institution.
Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors.
- Published in:
- 2009
- By:
- Publication type:
- journal article
The toxicities of modern targeted therapies: learning from the price of progress.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 5, p. 945, doi. 10.1007/s00432-018-2604-x
- By:
- Publication type:
- Article
Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 8, p. 1585, doi. 10.1007/s00432-017-2402-x
- By:
- Publication type:
- Article
Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 7, p. 1225, doi. 10.1007/s00432-017-2359-9
- By:
- Publication type:
- Article
Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 11, p. 2047, doi. 10.1007/s00432-015-1988-0
- By:
- Publication type:
- Article
Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: analysis of the phase 2, open-label, single-arm A2101 study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 12, p. 1985, doi. 10.1007/s00432-013-1529-7
- By:
- Publication type:
- Article
Developmental Therapeutics Implications of Next-Generation Sequencing in Human Herpesvirus 8-Negative Castleman Disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 11, p. N.PAG, doi. 10.15252/emmm.201910659
- By:
- Publication type:
- Article
T-Cell Prolymphocytic Leukemia: A Single-Institution Experience.
- Published in:
- Clinical Lymphoma & Myeloma, 2005, v. 6, n. 3, p. 234
- By:
- Publication type:
- Article
Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance.
- Published in:
- Biologics: Targets & Therapy, 2008, v. 2, n. 2, p. 201
- By:
- Publication type:
- Article
The clinical challenge of imatinib resistance in chronic myeloid leukemia: emerging strategies with new targeted agents.
- Published in:
- Targeted Oncology, 2006, v. 1, n. 4, p. 186, doi. 10.1007/s11523-006-0032-3
- By:
- Publication type:
- Article
Pevonedistat ( MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 4, p. 534, doi. 10.1111/bjh.13323
- By:
- Publication type:
- Article
Blinatumomab for the treatment of acute lymphoblastic leukemia.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 6, p. 1271, doi. 10.1007/s10637-015-0289-4
- By:
- Publication type:
- Article
Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Recent Advances and Future Strategies for Immune-Checkpoint Inhibition in Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Biomarkers for PD-1/PD-L1 Blockade Therapy in Non-Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
- Published in:
- 2016
- By:
- Publication type:
- journal article
Biomarkers for PD-1/PD-L1 Blockade Therapy in Non—Small-cell Lung Cancer: Is PD-Ll Expression a Good Marker for Patient Selection?
- Published in:
- Clinical Lung Cancer, 2016, v. 17, n. 5, p. 350, doi. 10.1016/j.cllc.2016.03.011
- By:
- Publication type:
- Article
ELR510444 Inhibits Tumor Growth and Angiogenesis by Abrogating HIF Activity and Disrupting Microtubules in Renal Cell Carcinoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0031120
- By:
- Publication type:
- Article
Effects of Clinically Relevant MPL Mutations in the Transmembrane Domain Revealed at the Atomic Level through Computational Modeling.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023396
- By:
- Publication type:
- Article
JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms.
- Published in:
- PLoS ONE, 2010, v. 5, n. 8, p. 1, doi. 10.1371/journal.pone.0012165
- By:
- Publication type:
- Article
New drugs in acute myeloid leukemia.
- Published in:
- Current Oncology Reports, 2002, v. 4, n. 5, p. 369, doi. 10.1007/s11912-002-0029-8
- By:
- Publication type:
- Article
Is Personalized Medicine Here?
- Published in:
- Oncology (08909091), 2016, v. 30, n. 4, p. 293
- By:
- Publication type:
- Article
A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 25, doi. 10.1007/s00262-016-1913-7
- By:
- Publication type:
- Article
SLAM Modification as an Immune-Modulatory Therapeutic Approach in Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4808, doi. 10.3390/cancers15194808
- By:
- Publication type:
- Article
Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models.
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 895, doi. 10.3390/cancers11070895
- By:
- Publication type:
- Article
Targeting both BET and CBP/EP300 proteins with the novel dual inhibitors NEO2734 and NEO1132 leads to anti‐tumor activity in multiple myeloma.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 1, p. 90, doi. 10.1111/ejh.13525
- By:
- Publication type:
- Article
Preclinical Testing of Erlotinib in a Transgenic Alveolar Rhabdomyosarcoma Mouse Model.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Preclinical Testing of Erlotinib in a Transgenic Alveolar Rhabdomyosarcoma Mouse Model.
- Published in:
- Sarcoma, 2011, p. 1, doi. 10.1155/2011/130484
- By:
- Publication type:
- Article
Multidrug resistance protein expression in chronic myeloid leukemia.
- Published in:
- Cancer (0008543X), 1999, v. 86, n. 5, p. 805, doi. 10.1002/(SICI)1097-0142(19990901)86:5<805::AID-CNCR16>3.0.CO;2-E
- By:
- Publication type:
- Article
A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission.
- Published in:
- Cancer (0008543X), 1999, v. 85, n. 7, p. 1506, doi. 10.1002/(SICI)1097-0142(19990401)85:7<1506::AID-CNCR11>3.0.CO;2-O
- By:
- Publication type:
- Article
Recombinant interferon-α therapy in patients with follicular lymphoma.
- Published in:
- Cancer (0008543X), 1998, v. 82, n. 10, p. 1821, doi. 10.1002/(SICI)1097-0142(19980515)82:10<1821::AID-CNCR3>3.0.CO;2-Q
- By:
- Publication type:
- Article
Comparison of technetium-99m sestamibi and indium-111 octreotide imaging in a patient with ewing's sarcoma before and after stem cell transplantation.
- Published in:
- Cancer (0008543X), 1997, v. 80, n. S12, p. 2478, doi. 10.1002/(SICI)1097-0142(19971215)80:12+<2478::AID-CNCR19>3.0.CO;2-9
- By:
- Publication type:
- Article
Novel Abl Kinase Inhibitors in Chronic Myeloid Leukemia in Blastic Phase and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, p. S113
- By:
- Publication type:
- Article
Management of Patients with Newly Diagnosed Chronic Myeloid Leukemia: Opportunities and Challenges.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, p. S51
- By:
- Publication type:
- Article
Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 3, p. 1121, doi. 10.1007/s10637-011-9670-0
- By:
- Publication type:
- Article
A phase I study of pemetrexed in patients with relapsed or refractory acute leukemia.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 323, doi. 10.1007/s10637-009-9369-7
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of XK469R (NSC 698215), a quinoxaline phenoxypropionic acid derivative, in patients with refractory acute leukemia.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 331, doi. 10.1007/s10637-008-9129-0
- By:
- Publication type:
- Article
9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-56461-4
- By:
- Publication type:
- Article
Glycogen Synthase Kinase-3β Inhibition with 9-ING-41 Attenuates the Progression of Pulmonary Fibrosis.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55176-w
- By:
- Publication type:
- Article
Treatment of Acute Lymphoblastic Leukaemia: A New Era.
- Published in:
- Drugs, 2007, v. 67, n. 15, p. 2153, doi. 10.2165/00003495-200767150-00004
- By:
- Publication type:
- Article
The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib.
- Published in:
- Journal of Cellular & Molecular Medicine, 2011, v. 15, n. 10, p. 2057, doi. 10.1111/j.1582-4934.2010.01218.x
- By:
- Publication type:
- Article
Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation.
- Published in:
- Journal of Cellular & Molecular Medicine, 2010, v. 14, n. 10, p. 2448, doi. 10.1111/j.1582-4934.2009.00832.x
- By:
- Publication type:
- Article
Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Molecular basis explanation for imatinib resistance of BCR-ABL due to T315I and P-loop mutations from molecular dynamics simulations.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Enzymatic Activity of Circulating Proteasomes Correlates With Clinical Behavior in Patients With Chronic Lymphocytic Leukemia.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 6, p. 1306, doi. 10.1002/cncr.23301
- By:
- Publication type:
- Article
Low Serum Albumin Level Is Associated With Cytomegalovirus Reactivation in Patients With Chronic Lymphoproliferative Diseases Treated With Alemtuzumab (Campath-1H)-based Therapies.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 11, p. 2478, doi. 10.1002/cncr.23031
- By:
- Publication type:
- Article
PEG-IFN-alpha-2b therapy in BCR-ABL-negative myeloproliferative disorders: final result of a phase 2 study.
- Published in:
- 2007
- By:
- Publication type:
- journal article
PEG-IFN-α-2b Therapy in BCR-ABL-negative Myeloproliferative Disorders.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 9, p. 2012, doi. 10.1002/cncr.23018
- By:
- Publication type:
- Article
Phase 1 study of tipifarnib in combination with imatinib for patients with chronic myelogenous leukemia in chronic phase after imatinib failure.
- Published in:
- 2007
- By:
- Publication type:
- journal article